Delaware
(State
or Other Jurisdiction
of
Incorporation)
|
000-30929
(Commission
File Number)
|
13-4087132
(IRS
Employer Identification No.)
|
£ |
Written
communications pursuant to Rule 425 under the Securities
Act.
|
£ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act.
|
£ |
Pre-commencement
communications pursuant to Rule 14d-2b under the Exchange
Act.
|
£ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act.
|
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(b) |
On
June 5, 2008, Beth F. Levine, Senior Vice President, General Counsel,
Chief Compliance Officer and Corporate Secretary of Keryx
Biopharmaceuticals, Inc. (the “Company”), submitted her resignation to the
Company. The resignation will be effective on June 27,
2008.
|
Keryx
Biopharmaceuticals, Inc.
(Registrant)
|
||
|
|
|
Date: June 6, 2008 | By: | /s/ James F. Oliviero |
James F.
Oliviero
Vice
President, Finance
|